Company page
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. is a publicly traded company on the American stock market under the ticker IOVA. The company has a market capitalization of approximately $1.75 billion. Iovance focuses on developing cell therapy products for cancer treatment.
- Ticker
- IOVA:NASDAQ
- Asset type
- Stock
- Market cap
- $1.75B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD